Concepedia

Jeremy S. Parker

JS

Statistics

Publications

38

Citations

1.2K

H-Index

23

Active since

1995

Affiliations

AstraZeneca (United Kingdom)(Current)

AstraZeneca (Brazil)

University of Cambridge

Cancer Research UK

AstraZeneca (Sweden)

Jeremy S. Parker is an author at AstraZeneca (United Kingdom) specializing in chemistry, engineering, and organic chemistry.

ORCID

Top concepts

Publications per year

1995–2022

38

Publications

38

A general approach for the site-selective modification of native proteins, enabling the generation of stable and functional antibody–drug conjugates

Stephen J. Walsh, Soleilmane Omarjee, Warren R. J. D. Galloway et al. · Chemical Science · 2018 · 120 citations · Full text

Design and optimisation of dendrimer-conjugated Bcl-2/xL inhibitor, AZD0466, with improved therapeutic index for cancer therapy

Claire Patterson, Srividya B. Balachander, Iain Grant et al. · Communications Biology · 2021 · 89 citations · Full text

Manganese(III) Acetate Mediated Oxidative Radical Cyclizations. Toward Vicinal All-Carbon Quaternary Stereocenters

Angus W. J. Logan, Jeremy S. Parker, Michal S. Hallside et al. · Organic Letters · 2012 · 56 citations

, , +13

Studies towards a postulated biomimetic Diels-Alder reaction for the synthesis of himgravine

Jack E. Baldwin, Richard Chesworth, Jeremy S. Parker et al. · Tetrahedron Letters · 1995 · 49 citations

, , +2

A Robust First-Pass Protocol for the Heck–Mizoroki Reaction

Paul M. Murray, John F. Bower, David K. Cox et al. · Organic Process Research & Development · 2013 · 48 citations

, , +12

Rows per page

1–5 of 38